Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-11

Clinical Trial Update: Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

View source ↗

Summary

A recruiting clinical trial characterizes circulating and tumor-infiltrating immune cells in malignant brain tumors to study the immune environment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pietro Mortini, MD, Prof. | Conditions: Brain Tumor, Primary, Brain Tumor - Metastatic | Status: RECRUITING